ArticlePharmaceutics2022
Influence of the Alcohols on the ZnO Synthesis and Its Properties: The Photocatalytic and Antimicrobial Activities.
Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
51 citing papers in PubMed, 101 citations in OpenAlex.
- Antibacterial Packaging for Cheese Based on Carboxymethyl Cellulose Composite with Zinc Oxide and Thyme Essential Oil.Foods (Basel, Switzerland) · 2026Article
- The Photocatalytic Activity of Photoresponsive Silver Nanoparticle/Zinc Oxide Composite Thin Films with Unprecedently Elevated Quantities of Silver.Nanomaterials (Basel, Switzerland) · 2026Article
- Enhanced electrochemical performance of eco-friendly Cr-doped ZnO/RGO nanocomposites for pioneering supercapacitor applications.Frontiers in chemistry · 2026Article
- Sunlight-Driven Photocatalysis in Hydrothermally Coupled ZnO/FeNanomaterials (Basel, Switzerland) · 2025Article
- Orange Peel-Mediated Green Synthesis of ZnO and CuO Nanoparticles: Evaluation for Antimicrobial Activity and Biocompatibility in Tissue Engineering.International journal of molecular sciences · 2025Article
- Highly Efficient Graphene Oxide/Zinc Oxide/Lignin Catalyst for Photocatalytic Degradation of Methylene Blue and Gentian Violet.Nanomaterials (Basel, Switzerland) · 2025Article
- Functional Properties and Safety Considerations of Zinc Oxide Nanoparticles Under Varying Conditions.Nanomaterials (Basel, Switzerland) · 2025Article
- Biomaterials Based on Bee Products and Their Effectiveness in Soft Tissue Regeneration.Materials (Basel, Switzerland) · 2025Article
- Nanomaterial ZnO Synthesis and Its Photocatalytic Applications: A Review.Nanomaterials (Basel, Switzerland) · 2025Review
- Synthesis of ZnO Nanoparticles byNanomaterials (Basel, Switzerland) · 2025Article
- Photocatalytic Degradation of Ciprofloxacin by GO/ZnO/Ag Composite Materials.Nanomaterials (Basel, Switzerland) · 2025Article
- Investigation of the photocatalytic potential of C/N-co-doped ZnO nanorods producedNanoscale advances · 2025Article
- Evaluation of Antibacterial Properties of Zinc Oxide Nanoparticles Against Bacteria Isolated from Animal Wounds.Pharmaceutics · 2025Article
- Size Distribution of Zinc Oxide Nanoparticles Depending on the Temperature of Electrochemical Synthesis.Materials (Basel, Switzerland) · 2025Article
- Tailoring CdO-CuO-ZnO Mixed Metal Oxide Nanocomposites for Anticancer Activity via Co-Precipitation Method.Nanotechnology, science and applications · 2025Article
- Monitoring the Antibacterial Activity of the Green Synthesized ZnO Nanoparticles on the Negative and Positive Gram Bacteria Mimicking Oral Environment by Using a Quartz Tuning Fork (QTF) Micromechanical Sensor.International journal of nanomedicine · 2025Article
- Multifunctional ZnO Nanoparticles Synthesized UsingBioinorganic chemistry and applications · 2025Article
- Aminoacid functionalised magnetite nanoparticles FeScientific reports · 2024Article
- Antimicrobial Hydroxyethyl-Cellulose-Based Composite Films with Zinc Oxide and Mesoporous Silica Loaded with Cinnamon Essential Oil.Pharmaceutics · 2024Article
- Understanding the Role of Solvent on the Growth of Zinc Oxide: Insight from Experiment and Molecular Dynamics Simulations.Langmuir : the ACS journal of surfaces and colloids · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 3 institutions in 1 country.
Funding
Abstract
Zinc oxide (ZnO) nanomaterials are used in various health-related applications, from antimicrobial textiles to wound dressing composites and from sunscreens to antimicrobial packaging. Purity, surface defects, size, and morphology of the nanoparticles are the main factors that influence the antimicrobial properties. In this study, we are comparing the properties of the ZnO nanoparticles obtained by solvolysis using a series of alcohols: primary from methanol to 1-hexanol, secondary (2-propanol and 2-butanol), and tertiary (tert-butanol). While the synthesis of ZnO nanoparticles is successfully accomplished in all primary alcohols, the use of secondary or tertiary alcohols does not lead to ZnO as final product, underlining the importance of the used solvent. The shape of the obtained nanoparticles depends on the alcohol used, from quasi-spherical to rods, and consequently, different properties are reported, including photocatalytic and antimicrobial activities. In the photocatalytic study, the ZnO obtained in 1-butanol exhibited the best performance against methylene blue (MB) dye solution, attaining a degradation efficiency of 98.24%. The comparative study among a series of usual model dyes revealed that triarylmethane dyes are less susceptible to photo-degradation. The obtained ZnO nanoparticles present a strong antimicrobial activity on a broad range of microorganisms (bacterial and fungal strains), the size and shape being the important factors. This permits further tailoring for use in medical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.